On insurance and the cost-sharing of pharmaceutical R&D
Martínez Giralt, Xavier (Universitat Autònoma de Barcelona. Departament d'Economia i d'Història Econòmica)
Barros, Pedro Pita (Universidade Nova de Lisboa)
Centre de Referència en Economia Analítica

Imprint:	Centre de Referencia en Economia Analítica, 2006
Description:	18 p.
Abstract:	Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for drug reimbursement. By incorporating these new elements, we aim at providing some building blocks towards an economic theory merging Ramsey pricing, equity concerns by governments and the strategic incentives, as governments also determine the reimbursement level in countries with a NHS-like system. This will have important implications to the application of Ramsey pricing principles to pharmaceutical products across countries.
Rights:	Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
Language:	Anglès
Series:	Barcelona economics working papers series; 293
Document:	Working paper
Subject:	Preus ; Indústria farmacèutica ; Ramsey pricing ; Coinsurance

Adreça alternativa: https://www.barcelonagse.eu/sites/default/files/working_paper_pdfs/293.pdf

18 p, 118.4 KB

The record appears in these collections:
Research literature > Working papers